Published in
American Society for Microbiology, Journal of Clinical Microbiology, 9(57), 2019
DOI: 10.1128/jcm.00798-19
Links
Tools
A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage
Journal article published in 2019 by
Ayesha Khan 
,
Lina M. Rivas,
Maria Spencer,
Rodrigo Martinez,
Marusella Lam,
Pamela Rojas,
Lorena Porte,
Francisco Silva,
Stephanie Braun,
Francisca Valdivieso,
Margareta Mv̈lhauser,
Mónica Lafourcade,
William R. Miller,
Patricia García,
Cesar A. Arias
and other authors.
,
Lina M. Rivas,
Maria Spencer,
Rodrigo Martinez,
Marusella Lam,
Pamela Rojas,
Lorena Porte,
Francisco Silva,
Stephanie Braun,
Francisca Valdivieso,
Margareta Mv̈lhauser,
Mónica Lafourcade,
William R. Miller,
Patricia García,
Cesar A. Arias
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Ceftaroline (CPT) is a broad-spectrum agent with potent activity against methicillin-resistant Staphylococcus aureus (MRSA). The sequence type 5 (ST5) Chilean-Cordobés clone, associated with CPT nonsusceptibility, is dominant in Chile, a region with high rates of MRSA infections.